Zafer Başlar

993 total citations
82 papers, 578 citations indexed

About

Zafer Başlar is a scholar working on Hematology, Genetics and Oncology. According to data from OpenAlex, Zafer Başlar has authored 82 papers receiving a total of 578 indexed citations (citations by other indexed papers that have themselves been cited), including 48 papers in Hematology, 35 papers in Genetics and 17 papers in Oncology. Recurrent topics in Zafer Başlar's work include Chronic Lymphocytic Leukemia Research (26 papers), Chronic Myeloid Leukemia Treatments (21 papers) and Lymphoma Diagnosis and Treatment (14 papers). Zafer Başlar is often cited by papers focused on Chronic Lymphocytic Leukemia Research (26 papers), Chronic Myeloid Leukemia Treatments (21 papers) and Lymphoma Diagnosis and Treatment (14 papers). Zafer Başlar collaborates with scholars based in Türkiye, Canada and United States. Zafer Başlar's co-authors include Muhlis Cem Ar, Burhan Ferhanoğlu, Şeniz Öngören, Ahmet Emre Eşkazan, Teoman Soysal, Nükhet Tüzüner, Birsen Ülkü, Ayşe Salihoğlu, Hilal Akı and Ömer Nurı Pamuk and has published in prestigious journals such as SHILAP Revista de lepidopterología, Blood and Frontiers in Immunology.

In The Last Decade

Zafer Başlar

72 papers receiving 560 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Zafer Başlar Türkiye 13 307 182 120 119 77 82 578
Liang‐Tsai Hsiao Taiwan 12 232 0.8× 114 0.6× 112 0.9× 118 1.0× 81 1.1× 50 477
Hideki Uchiumi Japan 13 249 0.8× 122 0.7× 66 0.6× 91 0.8× 53 0.7× 51 458
WY Au China 14 312 1.0× 109 0.6× 102 0.8× 100 0.8× 86 1.1× 47 549
Shuichi Mizuta Japan 18 547 1.8× 126 0.7× 265 2.2× 115 1.0× 76 1.0× 58 797
Renato Fanin Italy 17 367 1.2× 291 1.6× 251 2.1× 158 1.3× 102 1.3× 40 797
Laurence Sanhès France 10 167 0.5× 217 1.2× 101 0.8× 125 1.1× 66 0.9× 24 475
Emma Cacciola Italy 12 214 0.7× 211 1.2× 72 0.6× 75 0.6× 31 0.4× 42 521
Murat Tombuloğlu Türkiye 11 231 0.8× 84 0.5× 83 0.7× 46 0.4× 51 0.7× 63 453
Mahmut Bayık Türkiye 12 114 0.4× 93 0.5× 113 0.9× 123 1.0× 89 1.2× 35 443
Anna Czyż Poland 11 313 1.0× 126 0.7× 120 1.0× 73 0.6× 21 0.3× 62 586

Countries citing papers authored by Zafer Başlar

Since Specialization
Citations

This map shows the geographic impact of Zafer Başlar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zafer Başlar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zafer Başlar more than expected).

Fields of papers citing papers by Zafer Başlar

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zafer Başlar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zafer Başlar. The network helps show where Zafer Başlar may publish in the future.

Co-authorship network of co-authors of Zafer Başlar

This figure shows the co-authorship network connecting the top 25 collaborators of Zafer Başlar. A scholar is included among the top collaborators of Zafer Başlar based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zafer Başlar. Zafer Başlar is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Elverdi, Tuğrul, et al.. (2025). The validation of advanced-stage Hodgkin lymphoma international prognostic index (A-HIPI) in Turkish patients with classical Hodgkin lymphoma. Annals of Hematology. 104(3). 1765–1775. 2 indexed citations
2.
Başlar, Zafer, et al.. (2023). Relapsed refractory multiple myeloma with CNS involvement successfully treated with Elranatamab: first reported case. Frontiers in Immunology. 14. 1276295–1276295. 6 indexed citations
3.
Yılmaz, Umut, Tuğrul Elverdi, Ayşe Salihoğlu, et al.. (2022). Diagnosis and Management of Classical Hodgkin Lymphoma During the COVID-19 Pandemic. Current Problems in Cancer. 46(6). 100913–100913. 1 indexed citations
4.
Yücesan, Emrah, Özden Hatırnaz Ng, Fevzi Yalniz, et al.. (2020). Copy-number variations in adult patients with chronic immune thrombocytopenia. Expert Review of Hematology. 13(11). 1277–1287. 3 indexed citations
5.
Murt, Ahmet, Tuğrul Elverdi, Ahmet Emre Eşkazan, et al.. (2020). Hepatitis B reactivation in hematopoietic stem cell transplanted patients: 20 years of experience of a single center from a middle endemic country. Annals of Hematology. 99(11). 2671–2677. 3 indexed citations
6.
Öncül, Mahmut, et al.. (2019). Comparison of different cryopreservation protocols for human umbilical cord tissue as source of mesenchymal stem cells. Acta Histochemica. 121(3). 361–367. 15 indexed citations
7.
Soysal, Teoman, Ahmet Emre Eşkazan, Dilek Keskin, et al.. (2019). The Outcomes of Chronic Myeloid Leukemia Patients With Molecular Warning Responses During Imatinib Treatment According to the European LeukemiaNet 2013 Recommendations. Clinical Lymphoma Myeloma & Leukemia. 19(7). e377–e384. 2 indexed citations
8.
Erbilgin, Yücel, Ahmet Emre Eşkazan, Özden Hatırnaz Ng, et al.. (2018). Deep sequencing of BCR-ABL1 kinase domain mutations in chronic myeloid leukemia patients with resistance to tyrosine kinase inhibitors. Leukemia & lymphoma. 60(1). 200–207. 11 indexed citations
9.
Salihoğlu, Ayşe, Ahmet Emre Eşkazan, Muhlis Cem Ar, et al.. (2017). Use of Bendamustine Combined with Rituximab in Chronic Lymphocytic Leukemia Patients: A Single Center Experience. Blood. 130. 5349–5349.
10.
11.
Eşkazan, Ahmet Emre, Mahir Cengız, Muhlis Cem Ar, et al.. (2016). Imatinib reduces bone marrow fibrosis and overwhelms the adverse prognostic impact of reticulin formation in patients with chronic myeloid leukaemia. Journal of Clinical Pathology. 69(9). 810–816. 3 indexed citations
12.
Yemişen, Mücahit, İ̇lker İnanç Balkan, Ayşe Salihoğlu, et al.. (2016). The Changing Epidemiology of Bloodstream Infections and Resistance in Hematopoietic Stem Cell Transplantation Recipients. Turkish Journal of Hematology. 33(3). 216–222. 13 indexed citations
13.
Yavuzer, Serap, et al.. (2016). Analysis of thrombosis and bleeding complications in patients with polycythemia vera: a Turkish retrospective study. International Journal of Hematology. 105(1). 70–78. 8 indexed citations
14.
Zülfikar, Bülent, Kaan Kavaklı, Muhlis Cem Ar, et al.. (2014). A Polymorphism in the IL-5 Gene is Associated with Inhibitor Development in Severe Hemophilia A Patients. Turkish Journal of Hematology. 31(1). 17–24. 10 indexed citations
15.
Salihoğlu, Ayşe, Tuğrul Elverdi, Ìhsan Karadoǧan, et al.. (2014). Brentuximab vedotin for relapsed or refractory Hodgkin lymphoma: experience in Turkey. Annals of Hematology. 94(3). 415–420. 22 indexed citations
16.
Çetin, Güven, Ahmet Emre Eşkazan, Muhlis Cem Ar, et al.. (2014). Bone-Specific Alkaline Phosphatase Levels among Patients with Multiple Myeloma Receiving Various Therapy Options. Turkish Journal of Hematology. 31(4). 374–380. 1 indexed citations
17.
Ar, Muhlis Cem, Zafer Başlar, Teoman Soysal, et al.. (2009). The Effect of ZAP-70 Expression on Disease Progression in Early-Stage (Binet A) B-CLL Patients. Balkan Medical Journal. 2009(4). 317–321. 1 indexed citations
18.
Öngören, Şeniz, Muhlis Cem Ar, Ahmet Emre Eşkazan, et al.. (2009). Clonal Chromosomal Abnormalities in Philadelphia-Negative Cells and Their Clinical Significance in Patients with Chronic Myeloid Leukemia: Results of a Single Center. Turkiye Klinikleri Tip Bilimleri Dergisi. 29(2). 321–330. 1 indexed citations
19.
Pamuk, Ömer Nurı, Zafer Başlar, Şeniz Öngören, et al.. (2002). Overview of 321 patients with idiopathic thrombocytopenic purpura. Annals of Hematology. 81(8). 436–440. 77 indexed citations
20.
Ayan, Fadıl, et al.. (2000). Asymptomatic giant prolapsing right atrial myxoma: comparison of transthoracic and transesophageal echocardiography in pre-operative evaluation. Journal of clinical and basic cardiology. 3(3). 197–198. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Liang‐Tsai Hsiao Breakdown of academic impact, for papers by Hideki Uchiumi Breakdown of academic impact, for papers by WY Au Breakdown of academic impact, for papers by Shuichi Mizuta Breakdown of academic impact, for papers by Renato Fanin Breakdown of academic impact, for papers by Laurence Sanhès Breakdown of academic impact, for papers by Emma Cacciola Breakdown of academic impact, for papers by Murat Tombuloğlu Breakdown of academic impact, for papers by Mahmut Bayık Breakdown of academic impact, for papers by Anna Czyż
Rankless by CCL
2026